Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Anti-Leishmania Activity of Osthole Publisher



Kermani EK1 ; Sajjadi SE1 ; Hejazi SH2 ; Arjmand R3 ; Saberi S2 ; Eskandarian A2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Pharmacognosy, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Hezar Jerib Avenue, Isfahan, 73461-81746, Iran
  2. 2. Department of Medical Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Medical Parasitology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Source: Pharmacognosy Research Published:2016


Abstract

Background: Treatment of cutaneous leishmaniasis (CL) is occasionally highly resistant to pentavalent antimonials, the gold standard in pharmacotherapy of CL. Since there is no effective vaccine, the discovery of natural antileishmanial products as complementary therapeutic agents could be used to improve the current regimens. Objective: In this study in vitro and in vivo antileishmanial activities of osthole, a natural coumarin known to possess antibacterial and parasiticidal activities are evaluated. Materials and Methods: Leishmania major infected J774.A1 macrophages were treated with increasing concentrations of osthole. CL lesions of BALB/c mice were treated topically with 0.2% osthole. Results: Osthole exhibited dose-dependent leishmanicidal activity against intracellular amastigotes with IC 50 value of 14.95 μ g/ml. Treatment of CL lesions in BALB/c mice with osthole significantly declined lesion progression compared to untreated mice (P < 0.05), however did not result in recovery. Conclusion: Osthole demonstrated remarkable leishmanicidal activity in vitro. Higher concentrations of osthole may demonstrate the therapeutic property in vivo. © 2016 Pharmacognosy Research | Published by Wolters Kluwer - Medknow.
Related Docs
View other Related Docs
1. Evaluation of Leishmanicidal Activity of Oxypeucedanin and Isoimperatorin on Leishmania Major Promastigotes, Journal of Isfahan Medical School (2013)
2. Antileishmanial Activity of Prenylated Coumarins Isolated From Ferulago Angulata and Prangos Asperula, Research in Pharmaceutical Sciences (2016)
3. Therapeutic Effect of Topical Tamoxifen in Murine Cutaneous Leishmaniasis Caused by Leishmania Major, Antimicrobial Agents and Chemotherapy (2024)
4. Effect of Peel and Leaf Extract of Walnut (Juglans Regia L.) on Cutaneous Leishmaniasis Caused by Leishmania Major in Balb/C Mice, Journal of Chemical and Pharmaceutical Sciences (2016)
5. The Role of Liposomal Cpg Odn on the Course of L. Major Infection in Balb/C Mice, Iranian Journal of Parasitology (2010)
6. The Effects of Prednisolone and Mometasone on Wound Healing Caused by Leishmania Major in Balb/C Mice, Journal of Isfahan Medical School (2020)
7. Evaluation of the Antileishmanial Effect of Polyclonal Antibodies and Cationic Antimicrobial Peptides, Pathogens and Global Health (2023)
8. Development of Liposomes Loaded With Anti-Leishmanial Drugs for the Treatment of Cutaneous Leishmaniasis, Journal of Liposome Research (2013)
Experts (# of related papers)
View all Related Experts
Seyed Hossein Hejazi (54)
Ali Asilian (13)
Other Related Docs
9. Antimonial Treatment Failure Rate in Patients With Cutaneous Leishmaniasis, Tehran University Medical Journal (2018)
10. Effect of Combination Therapy With Systemic Glucantime and Pentoxifylline in the Treatment of Cutaneous Leishmaniasis, International Journal of Dermatology (2006)
11. Study of Therapeutic Effect of Different Concentrations of Imatinib on Balb/C Model of Cutaneous Leishmaniasis, AIMS Microbiology (2020)
12. The Study of the Inhibitory Effects of Aqueous and Ethanolic Extracts of Ziziphora Tenuior L. on the Proliferation of Leishmania Major Amastigotes, Iranian Journal of Dermatology (2018)
13. A Novel Strategy for Enhance Potentiation of Meglumine Antimoniate Against Leishmania Major in Vitro, Iranian Journal of Parasitology (2019)
14. Review of the Prevalence and Causes of Antimony Compounds Resistance in Different Societies: Review Article, Tehran University Medical Journal (2017)
15. Immunization Against Leishmania Major Using Uv-Irradiated Promastigote in Experimental Model Balb/C Mice, Biochemical and Cellular Archives (2017)
16. Preparation and Characterization of Itraconazole Loaded Nanomicelles Based on Dextran–Behenic Acid for Cutaneous Leishmaniasis Treatment, Drug Development and Industrial Pharmacy (2021)
17. Treatment Role of Terpenoid Fraction of Perovskia Abrotanoides Kar. on Zoonotic Cutaneous Leishmaniasis in Animal Model, Traditional and Integrative Medicine (2022)
18. Comparision Effectivness of Extracts of Thyme, Yarrow, Henna and Garlic on Cutaneous Leishmaniasis Caused by L. Major in Animal Model (Balb/C), Journal of Medicinal Plants (2009)
19. A Survey on Inhibitory Effect of Whole-Body Extraction and Secretions of Lucilia Sericata’S Larvae on Leishmania Major in Vitro, Advanced Biomedical Research (2020)
20. The Efficacy of Treatment With Intralesional Meglumine Antimoniate Alone, Compared With That of Cryotherapy Combined With the Meglumine Antimoniate or Intralesional Sodium Stibogluconate, in the Treatment of Cutaneous Leishmaniasis, Annals of Tropical Medicine and Parasitology (2003)
21. Topical Effectiveness of Different Concentrations of Nanosilver Solution on Leishmania Major Lesions in Mice (Balb/C), Journal of Isfahan Medical School (2011)
22. Evaluation of Different Concentrations of Imatinib on the Viability of Leishmania Major: An in Vitro Study, Advanced Biomedical Research (2019)
23. Investigating in Vitro Anti-Leishmanial Effects of Silibinin and Silymarin on Leishmania Major, Annals of parasitology (2018)
24. Comparison of Three Different Therapies for Cutaneous Leishmaniasis and Identification of the Etiologic Isolates in Isfahan, Iran, Archives of Iranian Medicine (2020)
25. Efficacy of Paromomycin Ointment in the Treatment of Cutaneous Leishmaniasis: Results of a Double-Blind, Randomized Trial in Isfahan, Iran, Annals of Tropical Medicine and Parasitology (2005)
26. Serum Monocyte Chemotactic Protein-1 and Nitric Oxide in Cutaneous Leishmaniasis Patients Before and After Treatment With Glucantime, Journal of Isfahan Medical School (2012)
27. A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Itraconazole in the Treatment of Cutaneous Leishmaniasis, Journal of the European Academy of Dermatology and Venereology (2005)
28. Effect of Leishmania Gerbilli Injection on Mice Immunization Against Cutaneous Leishmaniasis (Cl) Caused by Leishmania Major, Pakistan Journal of Biological Sciences (2007)
29. Butanol Fraction of Kelussia Odoratissima Mozaff Inhibits the Growth of Leishmania Major Promastigote and Amastigote, World's Veterinary Journal (2020)
30. In Vitro Antileishmanial Activity of Falcaria Vulgaris Fractions on Leishmania Major, Jundishapur Journal of Natural Pharmaceutical Products (2017)
31. Comparison of Pro-Inflammatory Cytokines of Non-Healing and Healing Cutaneous Leishmaniasis, Scandinavian Journal of Immunology (2017)
32. Immune Response Measured in Human Volunteers Vaccinated With Autoclaved Leishmania Major Vaccine Mixed With Low Dose of Bcg, Clinical and Experimental Immunology (2003)
33. Vaccination in Leishmaniasis: A Review Article, Iranian Biomedical Journal (2022)
34. Anti-Leishmaniasis Effect of Staphylococcus Aureus Protein a on the Size of the Lesion and Parasitic Load, Advanced Biomedical Research (2023)
35. Comparative Effect of Topical Trichloroacetic Acid and Intralesional Meglumine Antimoniate in the Treatment of Acute Cutaneous Leishmaniasis, International Journal of Pharmacology (2006)
36. In Vitro Study of the Leishmanicidal Activity of Perovskia Abrotanoides Terpenoid-Rich Fractions Against Leishmania Major (Mrho/Ir/75/Er), Advanced Biomedical Research (2023)
37. Combinatorial Delivery of Antigen and Tlr Agonists Via Plga Nanoparticles Modulates Leishmania Major-Infected-Macrophages Activation, Biomedicine and Pharmacotherapy (2021)
38. Comparison of Intralesionally Injected Zinc Sulfate With Meglumine Antimoniate in the Treatment of Acute Cutaneous Leishmaniasis, Dermatology (2004)
39. Treatment of Cutaneous Leishmaniasis: Cassia Fistula Fruit Gel-Intralesional Glucantime Vs. Placebo Gel- Intralesional Glucantime Combination, Tehran University Medical Journal (2010)
40. Topical Effectiveness of Different Concentrations of Nanosilver Solution on Leishmania Major Lesions in Balb/C Mice, Journal of Vector Borne Diseases (2012)
41. In Vitro Anti-Leishmanial Activity of Satureja Hortensis and Artemisia Dracunculus Extracts on Leishmania Major Promastigotes, Journal of Parasitic Diseases (2016)
42. Recombinant C-Reactive Protein: A Potential Candidate for the Treatment of Cutaneous Leishmaniasis of Balb/C Mice Caused by Leishmania Major, Acta Parasitologica (2021)
43. Treatment of Acute Cutaneous Leishmaniasis With Intralesional Injection of Meglumine Antimoniate: Comparison of Conventional Technique With Mesotherapy Gun, International Journal of Dermatology (2010)
44. Comparative Study of the Efficacy of Combined Cryotherapy and Intralesional Meglumine Antimoniate (Glucantime®) Vs. Cryotherapy and Intralesional Meglumine Antimoniate (Glucantime®) Alone for the Treatment of Cutaneous Leishmaniasis, International Journal of Dermatology (2004)
45. A Comparative Study Between the Efficacy of Systemic Meglumine Antimoniate Therapy With Standard or Low Dose Plus Oral Omeprazole in the Treatment of Cutaneous Leishmaniasis, Journal of Vector Borne Diseases (2008)
46. The Effect of Intralesional Meglumine Antimoniate (Glucantime) Versus a Combination of Topical Trichloroacetic Acid 50% and Local Heat Therapy by Non-Ablative Radiofrequency on Cutaneous Leishmaniasis Lesions, Journal of Research in Medical Sciences (2012)
47. Pcr-Rflp Diagnosis and Characterization of Leishmania Species Causing Human Cutaneous Leishmaniasis and Evaluation of Treatment Times With Glucantime in These Patients, Tropical Biomedicine (2016)
48. Comparison of Protein Profile of Killed and Autoclaved Leishmania Major Using Polyacrylamide Gel Electrophoresis, Journal of Isfahan Medical School (2013)
49. The Role of Bax in the Apoptosis of Leishmania-Infected Macrophages, Microbial Pathogenesis (2020)
50. Locked Nucleic Acid -Anti- Let-7A Induces Apoptosis and Necrosis in Macrophages Infected With Leishmania Major, Microbial Pathogenesis (2018)